Seutic Pharma Private Limited loan details
Charges taken from banks & financial institutesData last updated:
Amount in (₹)
Seutic Pharma Private Limited has 11 charges registered with the Registrar of Companies: 10 open charges worth Rs 63.60 Cr and 1 satisfied charge worth Rs 4.00 M. The most recent charge was created on 24 Sep 2025 for Rs 4.03 M and is open.
Charges Breakdown by Lending Institutions
- Others : 63.60 Cr
₹63.60 crore
₹0.40 crore
1
Others
Creation
24 Sep 2025
₹0.40 cr
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 100320825 View Details | Others | ₹ 0.40 | 10 Jan 2020 | - | 12 Mar 2021 | Satisfied |
| 101159444 View Details | Others | ₹ 0.40 | 24 Sep 2025 | - | - | Open |
| 101026748 View Details | Others | ₹ 5.00 | 07 Jan 2025 | - | - | Open |
| 100652332 View Details | Others | ₹ 0.73 | 30 Sep 2022 | - | - | Open |
| 100562007 View Details | Others | ₹ 1.00 | 30 Dec 2021 | - | - | Open |
| 100483700 View Details | Others | ₹ 28.18 | 30 Sep 2021 | 26 Mar 2024 | - | Open |
| 100397784 View Details | Others | ₹ 0.12 | 18 Sep 2020 | - | - | Open |
| 100397817 View Details | Others | ₹ 0.39 | 16 Jun 2020 | - | - | Open |
| 100397792 View Details | Others | ₹ 1.14 | 08 Jun 2020 | 08 Nov 2021 | - | Open |
| 100089532 View Details | Others | ₹ 2.00 | 10 Mar 2017 | 12 Mar 2021 | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.